Zenotech Laboratories Q2 Results FY27: Net Loss Rs 2.57 Cr on Revenue of Rs 6.13 Cr
- October 28, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Zenotech Laboratories Q2 Results FY27 were declared on 28 October 2026 as standalone results for the July to September 2026 quarter. Revenue fell 40.08% year on year to Rs 6.13 Cr from Rs 10.23 Cr, and the company reported a net loss of Rs 2.57 Cr against a loss of Rs 0.84 Cr a year earlier. These quarterly results show a weaker YoY picture across the lines.
Zenotech Laboratories Ltd (ZENOTECH) Q2 Results FY27 announced on 28 October 2026, covering the company’s financial performance for the July to September quarter. Standalone results show revenue of Rs 6.13 Cr and a net loss of Rs 2.57 Cr, both weaker than the same quarter last year, with no consolidated statement involved. The results date and the figures in Zenotech Laboratories Q2 Results FY27 are drawn from the filing on NSE and BSE.
This Zenotech Laboratories Q2 Results results analysis covers the financial highlights, the business drivers, the outlook and the risks. The Financial Highlights table below sets each standalone line against the same quarter last year.
Click Here – Get Free Investment Predictions
Zenotech Laboratories Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 6.13 Cr | Rs 10.23 Cr | -40.08% YoY |
| Operating Profit | Rs -3.05 Cr | Rs 1.29 Cr | -336.43% YoY |
| Net Profit (PAT) | Rs -2.57 Cr | Rs -0.84 Cr | -205.95% YoY |
Source: company filing for Zenotech Laboratories Q2 Results FY27, 28 October 2026. Figures in Rs Crore, Standalone basis.
Key Takeaways from Zenotech Laboratories Q2 Results: What Stands Out
- Revenue of Rs 6.13 Cr was 40.08% lower than the Rs 10.23 Cr reported a year earlier, so the YoY growth figure is negative.
- Net profit was a loss of Rs 2.57 Cr, compared with a loss of Rs 0.84 Cr in the same quarter last year, a swing of -205.95% in Zenotech Laboratories Q2 Results FY27.
- Operating Profit was Rs -3.05 Cr, against Rs 1.29 Cr a year earlier, a change of -336.43% on the standalone results.
- Debt-to-assets was 0.00 in FY26, a point the performance analysis picks up alongside the quarterly numbers.
Zenotech Laboratories Q2 Results FY27: Performance Analysis
Zenotech Laboratories reported lower revenue and a larger loss in the July to September 2026 quarter. Revenue fell 40.08% year on year to Rs 6.13 Cr, while the net loss widened to Rs 2.57 Cr from Rs 0.84 Cr, as the standalone results show.
The results analysis shows the pressure sitting at the operating level too. Operating Profit moved from Rs 1.29 Cr to Rs -3.05 Cr, a change of -336.43%. The net profit margin stood at -41.9% against -8.2% in the comparison quarter, which frames the Zenotech Laboratories Q2 Results read.
For readers following the quarterly results, the next disclosures will show whether revenue stabilises and whether the loss narrows from the Rs 2.57 Cr reported now, since both lines moved the wrong way over the year. Univest users can track the same Zenotech Laboratories Q2 Results FY27 figures on the Univest app, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Debt-Free Position – The business factors behind the quarterly results start with the balance sheet. The company is almost debt free, with a debt-to-assets ratio of 0.00 in FY26, so the loss in Zenotech Laboratories Q2 Results FY27 is not tied to borrowing.
Revenue Decline – Revenue declined 40.08% year on year to Rs 6.13 Cr. The supplied data confirms the fall but does not establish the specific cause, so this section sticks to the reported figures.
Operating Profit Swing – Operating Profit moved to Rs -3.05 Cr from Rs 1.29 Cr a year earlier, and the net loss widened to Rs 2.57 Cr. Together these changes explain the YoY direction of the net profit line, and they sit alongside the debt-free position described above.
FY27 Outlook After Zenotech Laboratories Q2 Results
The outlook after Zenotech Laboratories Q2 Results FY27 depends on the quarters still to be reported. Full-year FY27 results will be the sum of the quarters, so the FY27 picture will be built from the next quarterly results and from conditions disclosed by the company as they emerge, rather than from any guidance quoted here.
Return on equity was -1.12% in FY26, and net profit has now stayed negative in the latest quarter, a pairing worth tracking in the next results analysis. Investors can also follow Univest Screener to compare how revenue and net profit move later, which leads into the risks.
Key Risks to Watch After Zenotech Laboratories Q2 Results FY27
Revenue Decline
Revenue declined 40.1% year on year to Rs 6.13 Cr in the latest quarter. Anyone following Zenotech Laboratories Q2 Results FY27 should treat this fall in YoY growth as the first number to watch in later disclosures.
Net Loss
The company reported a net loss of Rs 2.57 Cr in the latest quarter, wider than the Rs 0.84 Cr loss a year earlier. Whether the loss narrows will show up in the next standalone results.
Weak Margin and Return on Equity
Net profit margin narrowed to -41.9% from -8.2% in the comparison quarter, and return on equity was low at -1.12% in FY26. Both figures are linked to the loss and the lower revenue.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Zenotech Laboratories Q2 Results FY27 show standalone revenue of Rs 6.13 Cr and a net loss of Rs 2.57 Cr, both weaker year on year. The quarterly results mark a lower revenue base, and Zenotech Laboratories Q2 Results remain the reference for the standalone results. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Zenotech Laboratories Q2 Results FY27
What are Zenotech Laboratories Q2 Results FY27?
Ans. Zenotech Laboratories Q2 Results FY27 are the standalone results of ZENOTECH for July to September 2026. Alongside this, they report lower revenue and a larger net loss, as set out in the Quick Answer.
What is the results date for Zenotech Laboratories Q2 Results FY27?
Ans. The results date for Zenotech Laboratories Q2 Results FY27 is 28 October 2026, when the company declared its July to September numbers. Alongside this date, the Outlook section refers back to the same filing.
What revenue was reported in Zenotech Laboratories Q2 Results FY27?
Ans. Zenotech Laboratories reported revenue of Rs 6.13 Cr in Q2 FY27, compared with Rs 10.23 Cr a year earlier, so the Financial Highlights table shows a clear decrease.
What net profit was reported in Zenotech Laboratories Q2 Results FY27?
Ans. Zenotech Laboratories reported a net loss of Rs 2.57 Cr in Q2 FY27, against a loss of Rs 0.84 Cr, which means the Performance Analysis section describes a wider loss year on year.
How much YoY growth did revenue show in Zenotech Laboratories Q2 Results FY27?
Ans. Revenue showed YoY growth of -40.08% in Q2 FY27, falling to Rs 6.13 Cr from Rs 10.23 Cr, while the net loss widened, as the Key Takeaways section explains in more detail.
Did net profit rise or fall in Zenotech Laboratories Q2 Results?
Ans. Zenotech Laboratories Q2 Results show net profit falling to a loss of Rs 2.57 Cr from a loss of Rs 0.84 Cr a year ago, so the net profit line moved down, as covered in the Performance Analysis.
What was the Operating Profit in Zenotech Laboratories Q2 Results FY27?
Ans. Operating Profit in Zenotech Laboratories Q2 Results FY27 was Rs -3.05 Cr, compared with Rs 1.29 Cr a year earlier, which means the change was -336.43%, as the Performance Analysis section sets out.
Are Zenotech Laboratories Q2 Results consolidated results or standalone results?
Ans. Zenotech Laboratories Q2 Results are standalone results, not consolidated results. Alongside this basis, the Financial Highlights table lists every line on the same standalone footing, as the introduction of this article states.
What business factors shaped Zenotech Laboratories Q2 Results FY27?
Ans. Zenotech Laboratories Q2 Results FY27 were shaped by an almost debt free balance sheet, with a debt-to-assets ratio of 0.00 in FY26, alongside lower revenue, as the Key Business Factors section explains.
What are the key risks after Zenotech Laboratories Q2 Results FY27?
Ans. The key risks after Zenotech Laboratories Q2 Results FY27 are a 40.1% revenue decline, a net loss of Rs 2.57 Cr and a margin of -41.9%, as detailed in the Key Risks section.
What is the outlook after Zenotech Laboratories Q2 Results?
Ans. The outlook after Zenotech Laboratories Q2 Results depends on the remaining FY27 quarters, which means later disclosures will matter. Return on equity was -1.12% in FY26, which the FY27 Outlook section uses as context.
Where can I find the complete Zenotech Laboratories Q2 Results FY27 data?
Ans. The complete Zenotech Laboratories Q2 Results FY27 data sits in the Financial Highlights table above. Alongside it, Univest lists these numbers on the Zenotech stock page, which the Conclusion points to.
